180 related articles for article (PubMed ID: 22261338)
1. RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.
Ali S; Ahmad A; Aboukameel A; Bao B; Padhye S; Philip PA; Sarkar FH
Cancer Lett; 2012 Jun; 319(2):173-181. PubMed ID: 22261338
[TBL] [Abstract][Full Text] [Related]
2. Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells".
Bao B; Wang Z; Ali S; Kong D; Li Y; Ahmad A; Banerjee S; Azmi AS; Miele L; Sarkar FH
Cancer Lett; 2018 Jun; 423():153. PubMed ID: 29606293
[TBL] [Abstract][Full Text] [Related]
3. Retraction notice to: Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents.
Ali S; Varghese L; Pereira L; Tulunay-Ugur OE; Kucuk O; Carey TE; Wolf GT; Sarkar FH
Cancer Lett; 2018 Jun; 423():154. PubMed ID: 29606294
[TBL] [Abstract][Full Text] [Related]
4. KRAS above and beyond - EGFR in pancreatic cancer.
Siveke JT; Crawford HC
Oncotarget; 2012 Nov; 3(11):1262-3. PubMed ID: 23174662
[No Abstract] [Full Text] [Related]
5. RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development.
Pichiorri F; Suh SS; Rocci A; De Luca L; Taccioli C; Santhanam R; Zhou W; Benson DM; Hofmainster C; Alder H; Garofalo M; Di Leva G; Volinia S; Lin HJ; Perrotti D; Kuehl M; Aqeilan RI; Palumbo A; Croce CM
Cancer Cell; 2010 Oct; 18(4):367-81. PubMed ID: 20951946
[TBL] [Abstract][Full Text] [Related]
6. RETRACTED: Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity.
Ito H; Duxbury M; Zinner MJ; Ashley SW; Whang EE
Surgery; 2004 Sep; 136(3):548-56. PubMed ID: 15349101
[TBL] [Abstract][Full Text] [Related]
7. RETRACTED: A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells.
Mehta PP; Kung PP; Yamazaki S; Walls M; Shen A; Nguyen L; Gehring MR; Los G; Smeal T; Yin MJ
Cancer Lett; 2011 Jan; 300(1):30-9. PubMed ID: 20926183
[TBL] [Abstract][Full Text] [Related]
8. miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.
Yu S; Lu Z; Liu C; Meng Y; Ma Y; Zhao W; Liu J; Yu J; Chen J
Cancer Res; 2010 Jul; 70(14):6015-25. PubMed ID: 20610624
[TBL] [Abstract][Full Text] [Related]
9. RETRACTED: EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway.
Ma Q; Zhang Y; Liang H; Zhang F; Liu F; Chen S; Hu Y; Jiang L; Hao Y; Li M; Liu Y
Cancer Lett; 2018 Aug; 430():97-108. PubMed ID: 29778567
[TBL] [Abstract][Full Text] [Related]
10. [Progress of targeted therapy related to K-ras mutation].
Li ZW; Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):59-61. PubMed ID: 22455857
[No Abstract] [Full Text] [Related]
11. MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
Keklikoglou I; Hosaka K; Bender C; Bott A; Koerner C; Mitra D; Will R; Woerner A; Muenstermann E; Wilhelm H; Cao Y; Wiemann S
Oncogene; 2015 Sep; 34(37):4867-78. PubMed ID: 25500542
[TBL] [Abstract][Full Text] [Related]
12. The KRAS-PDEδ interaction is a therapeutic target.
Cancer Discov; 2013 Jul; 3(7):OF20. PubMed ID: 23847364
[TBL] [Abstract][Full Text] [Related]
13. RAS oncogenic signal upregulates EZH2 in pancreatic cancer.
Fujii S; Fukamachi K; Tsuda H; Ito K; Ito Y; Ochiai A
Biochem Biophys Res Commun; 2012 Jan; 417(3):1074-9. PubMed ID: 22222375
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mammalian ras effector function.
Hall A; Calés C; Hancock JF; Lloyd A; Self A; Gardener S; Houslay MD; Wakelam MJ; Marshall CJ
Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 2():855-62. PubMed ID: 3076100
[No Abstract] [Full Text] [Related]
15. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
16. Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.
Rachagani S; Senapati S; Chakraborty S; Ponnusamy MP; Kumar S; Smith LM; Jain M; Batra SK
Br J Cancer; 2011 Mar; 104(6):1038-48. PubMed ID: 21364589
[TBL] [Abstract][Full Text] [Related]
17. RETRACTED: Overlapping signal sequences control nuclear localization and endoplasmic reticulum retention of GRP58.
Adikesavan AK; Unni E; Jaiswal AK
Biochem Biophys Res Commun; 2008 Dec; 377(2):407-412. PubMed ID: 18851953
[TBL] [Abstract][Full Text] [Related]
18. RETRACTED: Zinc moderates circular RNA CircFOXP1 expression in order to regulate ferroptosis during lung adenocarcinoma.
Li H; Liu L
Chem Biol Interact; 2022 Jan; 352():109760. PubMed ID: 34922903
[TBL] [Abstract][Full Text] [Related]
19. 11'-Deoxyverticillin A (C42) promotes autophagy through K-Ras/GSK3 signaling pathway in HCT116 cells.
Niu S; Yuan D; Jiang X; Che Y
Protein Cell; 2014 Dec; 5(12):945-9. PubMed ID: 25261996
[No Abstract] [Full Text] [Related]
20. RETRACTED: Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer.
Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
Surgery; 2004 Aug; 136(2):261-9. PubMed ID: 15300189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
